Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 195

The DOI matches its Crossref record.

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

Open access
Turner, N C, Strauss, S J, Sarker, D, Gillmore, R, Kirkwood, A, Hackshaw, A, Papadopoulou, A, Bell, J, Kayani, I, Toumpanakis, C, Grillo, F, Mayer, A, Hochhauser, D, Begent, R H, Caplin, M E, Meyer, T · 2010 · British Journal of Cancer

Abstract

BACKGROUND: The role of chemotherapy for neuroendocrine tumours remains controversial and there is no standard regimen. METHOD: We report the outcome for a consecutive series of chemonaive patients with metastatic or locally advanced neuroendocrine tumours treated with a combination of 5-fluorouracil (500 mg m(-2)), cisplatin (70 mg m(-2)) and streptozocin (1000 mg m(-2)) (FCiSt) administered three weekly for up to six cycles. Patients were assessed for radiological response, toxicity and survival. RESULTS: In the 79 patients assessable for response, treatment with FCiSt was associated with an overall response rate of 33% (38% for pancreatic primary sites and 25% for non-pancreatic primary sites). Stable disease occurred in a further 51%, with progression in 16%. The median time to progression was 9.1 months and median overall survival was 31.5 months. The most common grade 3-4 toxicity was neutropaenia (28% patients) but grade 3-4 infection was rare (7%). The most frequent non-haematological grade 3-4 toxicity was nausea and vomiting (17%). Prognostic factors included Ki-67, mitotic index, grade and chromogranin A, whereas response to chemotherapy was predicted by mitotic index, grade and alpha-fetoprotein. CONCLUSIONS: FCiSt is an effective regimen for neuroendocrine tumours with an acceptable toxicity profile. Grade and mitotic index are the best predictors of response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6605618

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 195

Metadata

Authors
Turner, N. C., Strauss, S. J., Sarker, D., Gillmore, R., Kirkwood, A., Hackshaw, A., Papadopoulou, A., Bell, J., Kayani, I., Toumpanakis, C., Grillo, F., Mayer, A., Hochhauser, D., Begent, R. H., Caplin, M. E., & Meyer, T.
Venue
British Journal of Cancer
Published
2010-03
Volume
102
Issue
7
Pages
1106-1112
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2007312936
Cited by
195
References
0
FWCI
11.11
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. https://app.cochat.ai/papers/10.1038/sj.bjc.6605618
The paper
Turner, N. C., Strauss, S. J., Sarker, D., Gillmore, R., Kirkwood, A., Hackshaw, A., Papadopoulou, A., Bell, J., Kayani, I., Toumpanakis, C., Grillo, F., Mayer, A., Hochhauser, D., Begent, R. H., Caplin, M. E., & Meyer, T. (2010). Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6605618

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.